Straits Times Index
3,328.58 -1.51 (-0.05%) Nikkei
38,789.52 -65.85 (-0.17%) Hang Seng
18,539.89 -281.27 (-1.49%) FTSE 100
8,254.18 -63.41 (-0.76%) Bitcoin USD
68,738.76 +267.12 (+0.39%) CMC Crypto 200
1,449.85 -46.61 (-3.12%)
INO Nov 2024 25.000 call
- GuruFocus.com
Inovio Pharmaceuticals Inc (INO) Q1 2024 Earnings Call Transcript Highlights: Strategic ...
Explore key financial outcomes and strategic updates from Inovio Pharmaceuticals Inc's first quarter of 2024, signaling robust progress and operational efficiency.
- PR Newswire
INOVIO Reports First Quarter 2024 Financial Results and Recent Business Highlights
INOVIO (NASDAQ:INO), a biotechnology company focused on developing and commercializing DNA medicines to help treat and protect people from HPV-related diseases, cancer, and infectious diseases, today announced its financial results for the first quarter of 2024 and provided an update on recent company developments.
- PR Newswire
INOVIO Reports Inducement Grants Under Inducement Plan
INOVIO (NASDAQ: INO), a biotechnology company focused on developing and commercializing DNA medicines to help treat and protect people from HPV-related diseases, cancer, and infectious diseases, today announced that it has made equity grants to two newly hired employees under its 2022 Inducement Plan (the "Inducement Plan").
